M
Michel D'Incan
Researcher at University of Auvergne
Publications - 175
Citations - 7729
Michel D'Incan is an academic researcher from University of Auvergne. The author has contributed to research in topics: Melanoma & Mycosis fungoides. The author has an hindex of 39, co-authored 160 publications receiving 6670 citations. Previous affiliations of Michel D'Incan include University of Clermont-Ferrand.
Papers
More filters
Journal ArticleDOI
A Comparison of Oral and Topical Corticosteroids in Patients with Bullous Pemphigoid
Pascal Joly,Jean-Claude Roujeau,Jacques Benichou,Catherine Picard,Brigitte Dréno,Emmanuel Delaporte,Loïc Vaillant,Michel D'Incan,Patrice Plantin,Christophe Bedane,Paul J Young,Philippe Bernard +11 more
TL;DR: Topical corticosteroid therapy is effective for both moderate and severe bullous pemphigoid and is superior to oral corticosterone therapy for extensive disease.
Journal ArticleDOI
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
Corine Bertolotto,Fabienne Lesueur,Sandy Giuliano,Thomas Strub,Mahaut de Lichy,Karine Bille,Philippe Dessen,Benoit d’Hayer,Hamida Mohamdi,Audrey Remenieras,Eve Maubec,Arnaud de la Fouchardière,Vincent Molinié,Pierre Vabres,Stéphane Dalle,N. Poulalhon,Tanguy Martin-Denavit,Luc Thomas,Pascale Andry-Benzaquen,Nicolas Dupin,F. Boitier,Annick Rossi,Jean-Luc Perrot,Bruno Labeille,Caroline Robert,Bernard Escudier,Olivier Caron,Laurence Brugières,Simon Saule,Betty Gardie,Sophie Gad,Stéphane Richard,Jérôme Couturier,Bin Tean Teh,Paola Ghiorzo,Lorenza Pastorino,Susana Puig,Celia Badenas,Håkan Olsson,Christian Ingvar,Etienne Rouleau,Rosette Lidereau,Philippe Bahadoran,Philippe Vielh,Eve Corda,Hélène Blanché,Diana Zelenika,Pilar Galan,François Aubin,Bertrand Bachollet,Celine Becuwe,Pascaline Berthet,Yves-Jean Bignon,Valérie Bonadona,Jean -Louis Bonafe,Marie -Noelle Bonnet-Dupeyron,Frédéric Cambazard,Jacqueline Chevrant-Breton,Isabelle Coupier,Sophie Dalac,Liliane Demange,Michel D'Incan,Catherine Dugast,Laurence Faivre,Lynda Vincent-Fetita,Marion Gauthier-Villars,Brigitte Gilbert,Florent Grange,Jean-Jacques Grob,Philippe Humbert,Nicolas Janin,Pascal Joly,Delphine Kerob,Christine Lasset,Dominique Leroux,Julien Levang,Jean -Marc Limacher,Cristina Bulai Livideanu,Michel Longy,Alain Lortholary,Dominique Stoppa-Lyonnet,Sandrine Mansard,Ludovic Mansuy,Karine Marrou,Christine Mateus,Christine Maugard,Nicolas Meyer,Catherine Noguès,Pierre Souteyrand,Laurence Venat-Bouvet,Hélène Zattara,Valérie Chaudru,Gilbert M. Lenoir,Mark Lathrop,Irwin Davidson,Marie-Françoise Avril,Florence Demenais,Robert Ballotti,Brigitte Bressac-de Paillerets +98 more
TL;DR: A germline missense substitution in MITF (Mi-E318K) is identified that occurred at a significantly higher frequency in genetically enriched patients affected with melanoma, RCC or both cancers, when compared with controls and provides insights into the link between SUMOylation, transcription and cancer.
Journal ArticleDOI
A Single Cycle of Rituximab for the Treatment of Severe Pemphigus
Pascal Joly,Hugo Mouquet,Jean-Claude Roujeau,Michel D'Incan,Danièle Gilbert,Serge Jacquot,Marie-Lise Gougeon,Christophe Bedane,Ralf Müller,Brigitte Dréno,Marie-Sylvie Doutre,Emmanuel Delaporte,Christine Pauwels,Nathalie Franck,Frédéric Caux,Catherine Picard,E. Tancrede-Bohin,Philippe Bernard,François Tron,Michael Hertl,Philippe Musette +20 more
TL;DR: A single cycle of rituximab is an effective treatment for pemphigus and its use should be limited to the most severe types of the disease.
Journal ArticleDOI
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.
Pascal Joly,Maud Maho-Vaillant,Catherine Prost-Squarcioni,Vivien Hébert,Estelle Houivet,Sébastien Calbo,Frédérique Caillot,Marie-Laure Golinski,Bruno Labeille,Catherine Picard-Dahan,Carle Paul,Marie-Aleth Richard,Jean-David Bouaziz,Sophie Duvert-Lehembre,Philippe Bernard,Frédéric Caux,Marina Alexandre,Saskia Ingen-Housz-Oro,Pierre Vabres,Emmanuel Delaporte,Gaëlle Quéreux,Alain Dupuy,Sébastien Debarbieux,Martine Avenel-Audran,Michel D'Incan,Christophe Bedane,Nathalie Beneton,Denis Jullien,Nicolas Dupin,Laurent Misery,Laurent Machet,Marie Beylot-Barry,Olivier Dereure,Bruno Sassolas,Thomas Vermeulin,Jacques Benichou,P. Musette +36 more
TL;DR: Data from this trial suggest that first-line use of rituximab plus short-termprednisone for patients with pemphigus is more effective than using prednisone alone, with fewer adverse events.
Journal ArticleDOI
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.
Franz Trautinger,Robert Knobler,Rein Willemze,Ketty Peris,Rudolph Stadler,Liliane Laroche,Michel D'Incan,Annamari Ranki,Nicola Pimpinelli,Pablo L. Ortiz-Romero,Reinhard Dummer,Teresa Estrach,Sean Whittaker +12 more
TL;DR: Skin-directed therapies are the most appropriate option for early-stage MF/SS and most patients can look forward to a normal life expectancy.